Single Tablet Regimen (STR) Simplification Study for HIV-1 Infected Patients
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- John Flaherty
Gilead Sciences
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
56 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Facility name not stated
Ponce, Puerto Rico
- Facility name not stated
San Juan, Puerto Rico
- Facility name not stated
Hobson City, Alabama, United States
- Facility name not stated
Phoenix, Arizona, United States
- Facility name not stated
Beverly Hills, California, United States
- Facility name not stated
Long Beach, California, United States
- Facility name not stated
Los Angeles, California, United States
- Facility name not stated
Oakland, California, United States
- Facility name not stated
San Diego, California, United States
- Facility name not stated
San Francisco, California, United States
- Facility name not stated
Tarzana, California, United States
- Facility name not stated
Denver, Colorado, United States
- Facility name not stated
Norwalk, Connecticut, United States
- Facility name not stated
Washington D.C., District of Columbia, United States
- Facility name not stated
Fort Lauderdale, Florida, United States
- Facility name not stated
Hollywood, Florida, United States
- Facility name not stated
Miami, Florida, United States
- Facility name not stated
Orlando, Florida, United States
- Facility name not stated
Pensacola, Florida, United States
- Facility name not stated
Port Saint Lucie, Florida, United States
- Facility name not stated
Safety Harbor, Florida, United States
- Facility name not stated
Tampa, Florida, United States
- Facility name not stated
Vero Beach, Florida, United States
- Facility name not stated
Atlanta, Georgia, United States
- Facility name not stated
Decatur, Georgia, United States
- Facility name not stated
Aurora, Illinois, United States
- Facility name not stated
Chicago, Illinois, United States
- Facility name not stated
Indianapolis, Indiana, United States
- Facility name not stated
Baltimore, Maryland, United States
- Facility name not stated
Boston, Massachusetts, United States
- Facility name not stated
Springfield, Massachusetts, United States
- Facility name not stated
Berkley, Michigan, United States
- Facility name not stated
Grosse Pointe Woods, Michigan, United States
- Facility name not stated
Minneapolis, Minnesota, United States
- Facility name not stated
St Louis, Missouri, United States
- Facility name not stated
Hillsborough, New Jersey, United States
- Facility name not stated
Newark, New Jersey, United States
- Facility name not stated
Newark, New Jersey, United States
- Facility name not stated
Somers Point, New Jersey, United States
- Facility name not stated
Albany, New York, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jul 2006
- Primary completion
- 31 Oct 2007
- Completion
- 31 Jan 2008
- Last update posted
- 10 Apr 2008
- Registered enrollment
- 300
- Registry id
- NCT00365612
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.